Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy (Science Translational Medicine)

S. R. Denmeade; A. M. Mhaka; D. M. Rosen; W. N. Brennen; S. Dalrymple; I. Dach; C. Olesen; B. Gurel; A. M. DeMarzo; G. Wilding; M. A. Carducci; C. A. Dionne; J. V. Møller; P. Nissen; S. B. Christensen; J. T. Isaacs

doi:10.1126/scitranslmed.3004546

Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy (Science Translational Medicine)

S. R. Denmeade, A. M. Mhaka, D. M. Rosen, W. N. Brennen, S. Dalrymple, I. Dach, C. Olesen, B. Gurel, A. M. DeMarzo, G. Wilding, M. A. Carducci, C. A. Dionne, J. V. Møller, P. Nissen, S. B. Christensen, J. T. Isaacs

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Article number	143er4
Journal	Science translational medicine
Volume	4
Issue number	143
DOIs	https://doi.org/10.1126/scitranslmed.3004546
State	Published - Jul 18 2012
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1126/scitranslmed.3004546

Cite this

Denmeade, S. R., Mhaka, A. M., Rosen, D. M., Brennen, W. N., Dalrymple, S., Dach, I., Olesen, C., Gurel, B., DeMarzo, A. M., Wilding, G., Carducci, M. A., Dionne, C. A., Møller, J. V., Nissen, P., Christensen, S. B., & Isaacs, J. T. (2012). Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy (Science Translational Medicine). Science translational medicine, 4(143), [143er4]. https://doi.org/10.1126/scitranslmed.3004546

Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy (Science Translational Medicine). / Denmeade, S. R.; Mhaka, A. M.; Rosen, D. M.; Brennen, W. N.; Dalrymple, S.; Dach, I.; Olesen, C.; Gurel, B.; DeMarzo, A. M.; Wilding, G.; Carducci, M. A.; Dionne, C. A.; Møller, J. V.; Nissen, P.; Christensen, S. B.; Isaacs, J. T.

In: Science translational medicine, Vol. 4, No. 143, 143er4, 18.07.2012.

Research output: Contribution to journal › Comment/debate › peer-review

Denmeade, SR, Mhaka, AM, Rosen, DM, Brennen, WN, Dalrymple, S, Dach, I, Olesen, C, Gurel, B, DeMarzo, AM, Wilding, G, Carducci, MA, Dionne, CA, Møller, JV, Nissen, P, Christensen, SB & Isaacs, JT 2012, 'Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy (Science Translational Medicine)', Science translational medicine, vol. 4, no. 143, 143er4. https://doi.org/10.1126/scitranslmed.3004546

Denmeade, S. R. ; Mhaka, A. M. ; Rosen, D. M. ; Brennen, W. N. ; Dalrymple, S. ; Dach, I. ; Olesen, C. ; Gurel, B. ; DeMarzo, A. M. ; Wilding, G. ; Carducci, M. A. ; Dionne, C. A. ; Møller, J. V. ; Nissen, P. ; Christensen, S. B. ; Isaacs, J. T. / Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy (Science Translational Medicine). In: Science translational medicine. 2012 ; Vol. 4, No. 143.

@article{778e179dded14a61b045b332d514b596,

title = "Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy (Science Translational Medicine)",

author = "Denmeade, {S. R.} and Mhaka, {A. M.} and Rosen, {D. M.} and Brennen, {W. N.} and S. Dalrymple and I. Dach and C. Olesen and B. Gurel and DeMarzo, {A. M.} and G. Wilding and Carducci, {M. A.} and Dionne, {C. A.} and M{\o}ller, {J. V.} and P. Nissen and Christensen, {S. B.} and Isaacs, {J. T.}",

year = "2012",

month = jul,

day = "18",

doi = "10.1126/scitranslmed.3004546",

language = "English (US)",

volume = "4",

journal = "Science Translational Medicine",

issn = "1946-6234",

publisher = "American Association for the Advancement of Science",

number = "143",

}

TY - JOUR

T1 - Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy (Science Translational Medicine)

AU - Denmeade, S. R.

AU - Mhaka, A. M.

AU - Rosen, D. M.

AU - Brennen, W. N.

AU - Dalrymple, S.

AU - Dach, I.

AU - Olesen, C.

AU - Gurel, B.

AU - DeMarzo, A. M.

AU - Wilding, G.

AU - Carducci, M. A.

AU - Dionne, C. A.

AU - Møller, J. V.

AU - Nissen, P.

AU - Christensen, S. B.

AU - Isaacs, J. T.

PY - 2012/7/18

Y1 - 2012/7/18

UR - http://www.scopus.com/inward/record.url?scp=84864130855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864130855&partnerID=8YFLogxK

U2 - 10.1126/scitranslmed.3004546

DO - 10.1126/scitranslmed.3004546

M3 - Comment/debate

AN - SCOPUS:84864130855

VL - 4

JO - Science Translational Medicine

JF - Science Translational Medicine

SN - 1946-6234

IS - 143

M1 - 143er4

ER -

Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy (Science Translational Medicine)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this